Top Markets
#1 Verus Coin Verus Coin +45.28%
#2 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +18.62%
#3 Status Status +18.22%
#4 GoPlus Security GoPlus Security +15.77%
#5 Wrapped NXM Wrapped NXM +15.47%
#6 Bedrock Bedrock +12.40%
#7 Ontology Gas Ontology Gas +11.94%
#8 DMT-NAT DMT-NAT +8.80%
#9 Pons Pons +7.62%
#10 Janction Janction +7.37%
Coin of the day
Verus Coin Verus Coin
Tetapan
Bahasa
MALAY
Mata wang
USD
Tema
Cadrenal Therapeutics, Inc. Common Stock Cadrenal Therapeutics, Inc. Common Stock

Cadrenal Therapeutics, Inc. Common Stock

CVKD
Kedudukan dalam Saham #33958
Cadrenal Therapeutics, Inc. operates as a biopharmaceutical enterprise... Cadrenal Therapeutics, Inc. operates as a biopharmaceutical enterprise primarily engaged in clinical development. The company's core focus is the advancement of Tecarfarin, a novel therapeutic agent that has received orphan drug designation. This treatment is engineered to prevent systemic thromboembolism originating from cardiac issues in patients suffering from both end-stage renal disease and atrial fibrillation. Established in 2022, the firm is headquartered in Ponte Vedra, Florida.
Harga Saham
$1.83
Disegerakkan terakhir: 2026-08-14
Modal Pasaran
$6.53M
Perubahan (1 hari)
-1.61%
Perubahan (1 tahun)
-85.57%
Negara
US
Perdagangan Cadrenal Therapeutics, Inc. Common Stock (CVKD)

Kategori

Healthcare
Sejarah harga saham bagi Cadrenal Therapeutics, Inc. Common Stock (CVKD)
Harga penutupan tertinggi: $1.89 pada 2026-08-01

Harga penutupan terendah: $46.78 pada 2023-01-01
Sejarah harga saham Cadrenal Therapeutics, Inc. Common Stock dari 2023 hingga 2026
Prestasi harga saham tahunan
Tahun Prestasi
2026 (TTM) -11.31%
2025 -35.19%
2024 69.00%
2023 0.00%
Harga saham bagi syarikat atau pesaing serupa
Syarikat Harga saham Perubahan 1thn% Negara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $505.24 28.63%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $846.09 29.41%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $731.69 6.47%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 $1.07K -6.40%
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $251.82 11.75%
BE